Surgical Innovations (SI) is pleased to announce that its latest conference appearance in...
- About us
- Investor Centre
- Group Companies
Nigel qualified as a Chartered Accountant in 1983 spending eight years with PwC before moving into industry. He managed the flotation of Stadium Group plc (“Stadium”) as Group Finance Director, before progressing to Group Chief Executive Officer in 2001. Under his leadership, Stadium divested several non-core businesses, focusing on the successful development of its electronic design and manufacturing capabilities in the UK and China to a global customer base. He joined 600 Group plc as Group Chief Executive Officer in 2012 and led the turnaround of the AIM-quoted global machine tool business (Colchester-Harrison), increasing strategic focus on the growth of its laser marking business (Electrox) until April 2015. Nigel has been Non-Executive Deputy Chairman of Transense Technologies plc, the AIM-quoted provider of sensor systems, since July 2015. Nigel was appointed Executive Chairman of Surgical Innovations Group plc in October 2015.
Doug Liversidge CBE
Remuneration Committee (Chairman), Audit Committee
Doug was educated in Sheffield and graduated with a degree in Metallurgy in 1957. Employed for 21 years at British Steel,
Doug attained the position of Chief Quality Manager.
After moving to G W Thornton as Managing Director and subsequently appointed Chief Executive, Doug guided the company through its flotation on the London Stock Exchange in March 1987 and was instrumental in the company winning numerous prestigious business awards including the Queen’s Award to Industry for Export Achievement and twice the Cutlers Acclaim Award for Corporate Growth. In 1991, Doug was awarded South Yorkshire Businessman of the Year. Doug was previously Chairman of Medilink Yorkshire and Humber. He is proud to have held the office of Master Cutler in Hallamshire from 1998 to 1999.
Doug has two honorary degrees from Sheffield University and Sheffield Hallam University and in 2000, was appointed Chairman of the South Yorkshire Learning & Skills Council by Government Office, Leeds. He was awarded the CBE in the 2000 New Year’s Honours List for services to industry. In 2012 Doug received the coveted Medilink Beacon Award for Outstanding Contribution to Healthcare in recognition of his continued services to the medical device industry.
Chair of the Leeds Innovation Health Hub and Fusion IP plc.
Professor Mike McMahon
Non-executive Clinical Director
Mike, a founder Director of Surgical Innovations Ltd, became Non-executive Clinical Director in October 2007. He is an
Emeritus Prof of Surgery at the University of Leeds, and practices as a Consultant Surgeon at the Nuffield Hospital, Leeds. He has carried out research and development of laparoscopic surgery and has demonstrated operative techniques in many countries. He is past President of the Association of Laparoscopic Surgeons of Great Britain and Ireland and was also Tutor in MIS at the Royal College of Surgeons and Director of the Leeds Institute for Minimally Invasive Therapy.
Mike’s past roles include President of the Pancreatic Society of Great Britain and Ireland and Chairman of the Education
Committee of the European Association of Endoscopic Surgery. He is a Non-executive Director of Cipher Surgical Limited.
Melanie qualified as a Chartered Management Accountant in 2006 training as a graduate with Corus before moving on to gain commercial exposure at the European Headquarters of Fellowes Inc. Melanie then moved on to Eaton Cooper Lighting & Safety Ltd, progressing through various roles to Business Partner – Finance before changing focus and moving to AESSEAL plc as Business Development Manager. It was her work here that led to a secondment over to Surgical Innovations Group plc as a consultant, working with the incumbent management on a full strategic review. Melanie transitioned over from AESSEAL in July 2015, and was appointed Finance Director (and Company Secretary) of the Group in the August, as well as General Manager of the main trading subsidiary. In October 2015 Melanie was appointed Managing Director of the Group.